ADPT — Adaptogenics Health Income Statement
0.000.00%
Last trade - 00:00- CA$0.57m
- CA$0.41m
Annual income statement for Adaptogenics Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Total Revenue | 0 | 0 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Total Operating Expenses | 0.141 | 0.271 |
| Operating Profit | -0.141 | -0.271 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | -0.141 | -0.266 |
| Net Income After Taxes | -0.141 | -0.266 |
| Net Income Before Extraordinary Items | ||
| Net Income | -0.141 | -0.266 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -0.141 | -0.266 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.009 | -0.016 |
| Dividends per Share |